Exam 1 Flashcards

1
Q

Non-coding parts of DNA =

A

INTRONS.

These are regulatory parts of DNA, they get spliced out. Larger role unknown.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Coding parts of DNA

A

exons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

primary RNA vs mRNA ->

A

primary RNA has introns, in mRNA the introns have been spliced out.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Alternative splicing happens

A

when splicing introns out of primary RNA to mRNA, this can create variants of the mRNA which will code for variant proteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 nucleotides =

A

1 codon -> codes for -> 1 amino acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sequences start with

A

methionine ! [AUG]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sequences end with

A

STOP codon.[UGA] or UGG?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SNP stands for

A

single nucleotide polymorphism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SNP that does not change resulting amino acid =

A

SILENT mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SNP that DOES change resulting amino acid =

A

mutation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SNP found in more than 1% of population =

A

Human genetic VARIATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SNP found in less than 1% of population =

A

mutation. Could be silent, could be pathological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Frame shift mutation

A

when you add IN a nucleotide or TAKE OUT a nucleotide, and the whole sequence then shifts one way. - FRAME SHIFT, problematic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Majority of SNPs are in

A

non-coding regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SNPs in non coding regions

A

[majority of SNPs]

  • could have an impact on the splicing. You might not generate the right protein, or this is where transcription happens and it could affect the process of transcription all together.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

G6PD deficiency

A

Glucose-6-phosphate dehydrogenase deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Actions of G6PD

A

part of pentose phosphate pathway, provides reducing energy [NADPH] to cells to protect them from ROS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

G6PD deficiency affects RBCs because

A

they are so vulnerable to oxidative stress r/t all the oxygen they carry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

G6PD deficiency leads to ->

A

hemolysis, RBC breakdown .

RBC breakdown happens faster than body can produce on own, this goes unnoticed until oxidative stress -> usually from oxidative drugs.

20
Q

Oxidative stress that leads to hemolysis with G6PD deficiency

A

anti-malarial!
Favism
aspirin, sulfonamides, nitrofurontin, dapsone, primaquine, quinidine,
[be careful wit anti-microbial, anti-biotics]

“OXIDATIVE DRUGS”

21
Q

SNPs are “stable” if

A

they are functional. If instead they were disadvantageous, they would die out

22
Q

Inheritance pattern of G6PD deficiency

A

X-linked recessive

23
Q

names of pseudocholinesterase

A

psuedocholinesterase
butyl cholinesterase
plasma cholinesterase

24
Q

Butylcholinesterase deficiency ->

A

prolonged apnea time!!
Different per individual.
Heterozygous gene expression -> 1/840??
Homo = 1/3200

In reality, lesser extents where people will have varying amounts

25
Q

Drugs affected by butyl cholinesterase deficiency includes:

A

SUCCINYLCHOLINE
MIVACURIUM
ester LAs -> cocaine, tetracaine, procaine.

26
Q

Inheritance pattern of butyl cholinesterase deficiency

A

autosomal recessive

27
Q

Butylcholinesterase deficiency is highest in

A

caucasian population. 4% affected -> partial deficiency

28
Q

Inheritance pattern of acute intermittent porphyria

A

autosomal dominant

29
Q

patho of acute intermittent porphyria

A

A mutation in the biosynthetic pathway of heme, this means one of the enzymes may be deficient, and if that enzyme is induced , you won’t be able to carry out the heme pathway -> clinical symptoms will result from build up of HEME PRE-CURSORS.

30
Q

Drugs that induce acute intermittent porphyria

A

are drugs that induce CYP system. Also induce ALA synthase.

i.e. barbiturates, estrogens, many anesthetic/sedative drugs.

31
Q

NAT2 =

A

N-acetyltransferase

32
Q

Slow acetylators more likely to have

A

drug [isoniazid] toxicity

33
Q

Fast acetylator are more likely to have

A

hepatotoxicity

34
Q

Acetyltransferase deficiency =

A

can result in lupus type syndrome.

autoimmune, disease skin, joints, kidney

35
Q

Inheritance pattern: slow acetyltransferase deficiency

A

single recessive gene

36
Q

NAT2 deficiency alleles

A

27 reported NAT 2 alleles.

2 COMMON ALLELLS that account for 90% of slow acetylators. (NAT25, NAT26)

37
Q

NAT2 has no

A

INTRONS. just coding regions.

38
Q

Acetyltransferase is important in metabolism:

A
isoniazid 
hydralazine 
procainamide 
dapsone 
sulfonamides
39
Q

Phase I reactions

A

Functionalization reactions

oxidation
reduction
hydrolysis

80% of drugs are metabolized this way

40
Q

Phase II reactions

A

conjugation reactions

large polar compound attached to functional groups. [covalent bond]

large increase in polarity
Acetylation, glucuronidation

41
Q

Acetylation and glucuronidation are examples of

A

phase ii reactions

42
Q

CYP450 are examples of

A

phase I reactions

43
Q

genome contains

A

3 billion base pairs

44
Q

average gene has

A

3,000 bases

45
Q

total # of protein coding genes =

A

22,300

46
Q

> 99% of nucleotide bases

A

are the same in all people

47
Q

GINA

A

genetic information nondiscrimination act [2008]